TGFBR2 c.454+4864T>A

Variant ID: 3-30696816-T-A

NM_003242.5(TGFBR2):c.454+4864T>A

This variant was identified in 4 publications

View GRCh38 version.




Publications:


Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy.

Breast Cancer Research : Bcr
Lei, Jieping J; Rudolph, Anja A; Moysich, Kirsten B KB; Rafiq, Sajjad S; Behrens, Sabine S; Goode, Ellen L EL; Pharoah, Paul P D PP; Seibold, Petra P; Fasching, Peter A PA; Andrulis, Irene L IL; Kristensen, Vessela N VN; Couch, Fergus J FJ; Hamann, Ute U; Hooning, Maartje J MJ; Nevanlinna, Heli H; Eilber, Ursula U; Bolla, Manjeet K MK; Dennis, Joe J; Wang, Qin Q; Lindblom, Annika A; Mannermaa, Arto A; Lambrechts, Diether D; García-Closas, Montserrat M; Hall, Per P; Chenevix-Trench, Georgia G; Shah, Mitul M; Luben, Robert R; Haeberle, Lothar L; Ekici, Arif B AB; Beckmann, Matthias W MW; Knight, Julia A JA; Glendon, Gord G; Tchatchou, Sandrine S; Alnæs, Grethe I Grenaker GI; Borresen-Dale, Anne-Lise AL; Nord, Silje S; Olson, Janet E JE; Hallberg, Emily E; Vachon, Celine C; Torres, Diana D; Ulmer, Hans-Ulrich HU; Rüdiger, Thomas T; Jager, Agnes A; van Deurzen, Carolien H M CH; Tilanus-Linthorst, Madeleine M A MM; Muranen, Taru A TA; Aittomäki, Kristiina K; Blomqvist, Carl C; Margolin, Sara S; Kosma, Veli-Matti VM; Hartikainen, Jaana M JM; Kataja, Vesa V; Hatse, Sigrid S; Wildiers, Hans H; Smeets, Ann A; Figueroa, Jonine J; Chanock, Stephen J SJ; Lissowska, Jolanta J; Li, Jingmei J; Humphreys, Keith K; Phillips, Kelly-Anne KA; , ; Linn, Sabine S; Cornelissen, Sten S; van den Broek, Sandra Alexandra J SA; Kang, Daehee D; Choi, Ji-Yeob JY; Park, Sue K SK; Yoo, Keun-Young KY; Hsiung, Chia-Ni CN; Wu, Pei-Ei PE; Hou, Ming-Feng MF; Shen, Chen-Yang CY; Teo, Soo Hwang SH; Taib, Nur Aishah Mohd NA; Yip, Cheng Har CH; Ho, Gwo Fuang GF; Matsuo, Keitaro K; Ito, Hidemi H; Iwata, Hiroji H; Tajima, Kazuo K; Dunning, Alison M AM; Benitez, Javier J; Czene, Kamila K; Sucheston, Lara E LE; Maishman, Tom T; Tapper, William J WJ; Eccles, Diana D; Easton, Douglas F DF; Schmidt, Marjanka K MK; Chang-Claude, Jenny J
Publication Date: 2015-02-10

Variant appearance in text: rs1019856
PubMed Link: 25849327
Variant Present in the following documents:
  • Main text
  • 13058_2015_Article_522.pdf
View BVdb publication page



Sickle Cell Disease in the Post Genomic Era: A Monogenic Disease with a Polygenic Phenotype.

Genomics Insights
Driss, A A; Asare, K O KO; Hibbert, J M JM; Gee, B E BE; Adamkiewicz, T V TV; Stiles, J K JK
Publication Date: 2009-07-30

Variant appearance in text: rs1019856
PubMed Link: 20401335
Variant Present in the following documents:
  • Main text
  • gei-2-2009-023.pdf
View BVdb publication page



Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-beta/BMP pathway.

British Journal Of Haematology
Nolan, Vikki G VG; Adewoye, Adeboye A; Baldwin, Clinton C; Wang, Ling L; Ma, Qianli Q; Wyszynski, Diego F DF; Farrell, John J JJ; Sebastiani, Paola P; Farrer, Lindsay A LA; Steinberg, Martin H MH
Publication Date: 2006-06

Variant appearance in text: rs1019856
PubMed Link: 16681647
Variant Present in the following documents:
  • Main text
View BVdb publication page



Association of klotho, bone morphogenic protein 6, and annexin A2 polymorphisms with sickle cell osteonecrosis.

Blood
Baldwin, Clinton C; Nolan, Vikki G VG; Wyszynski, Diego F DF; Ma, Qian-Li QL; Sebastiani, Paola P; Embury, Stephen H SH; Bisbee, Alice A; Farrell, John J; Farrer, Lindsay L; Steinberg, Martin H MH
Publication Date: 2005-07-01

Variant appearance in text: rs1019856
PubMed Link: 15784727
Variant Present in the following documents:
  • Main text
View BVdb publication page